Sfoglia per AUTORE
PIZZAMIGLIO G
Collezione AOU San Luigi di Orbassano
Items : 3
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society. in Infection / Infection. 2022 Jun;50(3):671-679. doi: 10.1007/s15010-021-01737-z. Epub 2021 Dec 7.
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Raia V; Riberi L; Poli P; Pizzamiglio G; Pisi G; Messore B; Mencarini V; Maschio M; Lucca F; Lucanto MC; Leonetti G; Leonardi S; Folino A; Ficili F; Francalanci M; Comello I; Collura M; Ciciriello F; Casciaro R; Bignamini E; Battistini F; Badolato R; Ambroni M; Alghisi F; Medino P; Daccò V; Cipolli M; Colombo C; Ros M; et alii...
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2021 Mar 22;10(3):338. doi: 10.3390/antibiotics10030338.
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Taccetti G; Francalanci M; Pizzamiglio G; Messore B; Carnovale V; Cimino G; Cipolli M;
Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. in Respiratory medicine / Respir Med. 2020 Sep;171:106073. doi: 10.1016/j.rmed.2020.106073. Epub 2020 Jul 3.
2020
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Salvatore D; Terlizzi V; Francalanci M; Taccetti G; Messore B; Biglia C; Pisi G; Calderazzo MA; Caloiero M; Pizzamiglio G; Majo F; Cresta F; Leonetti G; De Venuto D;